05:01 AM EDT, 07/29/2025 (MT Newswires) -- Astrazeneca ( AZN ) reported Q2 core earnings Tuesday of $2.17 per share, up 10% from a year earlier.

Analysts polled by FactSet expected $2.15.

Revenue for the quarter ended June 30 was $14.46 billion, compared with $12.94 billion a year earlier.

Analysts surveyed by FactSet expected $14.1 billion.

Astrazeneca ( AZN ) said it continues to expect 2025 core EPS to increase by a low double-digit percentage and its revenue to grow by a high single-digit percentage.

The company's shares were up 2.5% in recent premarket activity.